MicroRNAs Contribute to Hepatocellular Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is a significant global health burden, ranking as a leading cause of cancer-related mortality.
• HCC development is often linked to hepatic cirrhosis stemming from diverse causes like viral hepatitis, non-alcoholic fatty liver disease, and alcohol abuse.
• MicroRNAs (miRNAs), small non-coding RNA molecules, regulate gene expression post-transcriptionally and are implicated in various biological processes.

Purpose of the Study:

• To review recent advancements in understanding the role of miRNAs in hepatocellular carcinoma (HCC).
• To explore the potential of miRNAs as therapeutic targets for HCC management.
• To discuss the prognostic value of miRNAs in hepatocellular carcinoma.

Main Methods:

• Literature review of recent scientific publications.
• Synthesis of current research on miRNA involvement in HCC pathogenesis.
• Analysis of studies investigating miRNA-based therapeutic and prognostic strategies.

Main Results:

• Emerging evidence highlights the significant contribution of miRNAs to the development and progression of hepatocellular carcinoma.
• Dysregulation of specific miRNAs is frequently observed in HCC tissues.
• miRNAs have demonstrated potential as biomarkers for HCC diagnosis and prognosis.

Conclusions:

• MicroRNAs are integral to hepatocellular carcinoma development and progression.
• Targeting miRNAs presents a promising novel therapeutic avenue for HCC.
• Further research into miRNAs could lead to improved diagnostic and prognostic tools for HCC.